VYDAPTIV THERAPEUTICS
Dead / Abandoned — Abandoned — after inter partes decision (as of 21 Nov 2018)
What this means for you
This application is over — abandoned 21 Nov 2018. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86972981
- Mark type
- Stylized text
- Filed
- 12 Apr 2016
- Published for opposition
- 27 Sept 2016
- Abandoned
- 21 Nov 2018
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prophylaxis of infectious diseases, cancer and immune system diseases and disorders, auto immune system diseases, and blood disorders
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields
Owner
- APTEVO RESEARCH AND DEVELOPMENT LLC, SEATTLE, WA, US
- APTEVO RESEARCH AND DEVELOPMENT LLC, SEATTLE, WA, US
- Emergent Product Development Seattle, LLC, Seattle, WA, US
Prosecution history
- 21 Nov 2018 — ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
- 21 Nov 2018 — ABANDONMENT - AFTER INTER PARTES DECISION
- 21 Nov 2018 — OPPOSITION TERMINATED NO. 999999
- 21 Nov 2018 — OPPOSITION SUSTAINED NO. 999999
- 27 Mar 2017 — OPPOSITION INSTITUTED NO. 999999
- 25 Oct 2016 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 27 Sept 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Sept 2016 — PUBLISHED FOR OPPOSITION
- 07 Sept 2016 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Aug 2016 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Aug 2016 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Aug 2016 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Aug 2016 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Jul 2016 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Jul 2016 — NON-FINAL ACTION E-MAILED